| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/1078-0432.CCR-14-2808 |
| P8608 | Fatcat ID | release_pst7kpgl4rf5xjznevacmoq6cy |
| P698 | PubMed publication ID | 25934888 |
| P5875 | ResearchGate publication ID | 275717791 |
| P2093 | author name string | Chun Zhang | |
| Min Wang | |||
| Tracy Tang | |||
| Timothy Hoey | |||
| Aaron Sato | |||
| Ann M Kapoun | |||
| Austin Gurney | |||
| Fumiko Axelrod | |||
| Jennifer Cain | |||
| John Lewicki | |||
| Wan-Ching Yen | |||
| Belinda Cancilla | |||
| Christopher Bond | |||
| Jalpa Shah | |||
| Marcus M Fischer | |||
| Rene Meisner | |||
| Breanna Wallace | |||
| William R Henner | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2084-2095 | |
| P577 | publication date | 2015-05-01 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Targeting Notch signaling with a Notch2/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency | |
| P478 | volume | 21 |
| Q47782462 | A Novel Notch-YAP Circuit Drives Stemness and Tumorigenesis in Embryonal Rhabdomyosarcoma |
| Q92195300 | A randomized phase II trial of nab-paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer |
| Q38713045 | Antagonism of EGFR and Notch limits resistance to EGFR inhibitors and radiation by decreasing tumor-initiating cell frequency. |
| Q26744536 | Anti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical Appraisal |
| Q64102480 | Antibody-Drug Conjugates (ADC) Against Cancer Stem-Like Cells (CSC)-Is There Still Room for Optimism? |
| Q38971795 | Approaches for targeting cancer stem cells drug resistance |
| Q38845461 | Biology of lung cancer: genetic mutation, epithelial-mesenchymal transition, and cancer stem cells |
| Q38696803 | Breast cancer stem cells: are we ready to go from bench to bedside? |
| Q58781616 | Cancer Cells Exploit Notch Signaling to Redefine a Supportive Cytokine Milieu |
| Q42332008 | Cancer stem cell surface markers on normal stem cells |
| Q26779931 | Cancer stem cell targeted therapy: progress amid controversies. |
| Q65556507 | Chemotherapy Sensitizes Therapy-Resistant Cells to Mild Hyperthermia by Suppressing Heat Shock Protein 27 Expression in Triple-Negative Breast Cancer |
| Q33915812 | Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer |
| Q40216306 | Distinct prognostic values of four-Notch-receptor mRNA expression in ovarian cancer |
| Q49563630 | Dual tumor suppressive and oncogenic roles for Notch signaling in small cell lung cancer |
| Q92528442 | EMT and Stemness-Key Players in Pancreatic Cancer Stem Cells |
| Q26739625 | EMT in Breast Carcinoma-A Review |
| Q55314894 | Emerging application of genomics-guided therapeutics in personalized lung cancer treatment. |
| Q36854062 | Emerging therapeutic targets in metastatic progression: A focus on breast cancer |
| Q87179773 | Epithelial-mesenchymal transition: a new target in anticancer drug discovery |
| Q55099689 | Expression of Notch receptors and their ligands in pancreatic ductal adenocarcinoma. |
| Q47930128 | GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells |
| Q38830254 | Gain-of-function p53 activates multiple signaling pathways to induce oncogenicity in lung cancer cells. |
| Q37230991 | Genetic Diversity of Pancreatic Ductal Adenocarcinoma and Opportunities for Precision Medicine |
| Q52684501 | Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived Xenografts. |
| Q54256882 | High NOTCH1 mRNA Expression Is Associated with Better Survival in HNSCC. |
| Q91756542 | High delta-like ligand 4 expression correlates with a poor clinical outcome in gastric cancer |
| Q104684703 | High expression of Notch2 drives tongue squamous cell carcinoma carcinogenesis |
| Q41696862 | Identification and characterization of a novel Sso7d scaffold-based binder against Notch1. |
| Q46797418 | Inhibition of KPNA4 attenuates prostate cancer metastasis |
| Q51763437 | Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors. |
| Q46171322 | Intratumoural heterogeneity generated by Notch signalling promotes small-cell lung cancer |
| Q90685529 | Intriguing Roles for Endothelial ADAM10/Notch Signaling in the Development of Organ-Specific Vascular Beds |
| Q33779304 | LncRNA HOTAIR acts a competing endogenous RNA to control the expression of notch3 via sponging miR-613 in pancreatic cancer |
| Q61811250 | Long Noncoding RNA (lncRNA) MIR22HG Suppresses Gastric Cancer Progression through Attenuating NOTCH2 Signaling |
| Q53215067 | Lunatic Fringe is a potent tumor suppressor in Kras-initiated pancreatic cancer |
| Q98906859 | MYEOV increases HES1 expression and promotes pancreatic cancer progression by enhancing SOX9 transactivity |
| Q92255187 | MicroRNA-140-5p inhibits cell proliferation, migration and promotes cell apoptosis in gastric cancer through the negative regulation of THY1-mediated Notch signaling |
| Q59791901 | Moving Breast Cancer Therapy up a Notch |
| Q89964306 | Myoendothelial Junctions of Mature Coronary Vessels Express Notch Signaling Proteins |
| Q36830276 | NOTCH1 inhibition enhances the efficacy of conventional chemotherapeutic agents by targeting head neck cancer stem cell. |
| Q92669024 | NOTCH2/NOTCH3/DLL3/MAML1/ADAM17 signaling network is associated with ovarian cancer |
| Q36001853 | NOTCH3 Is Induced in Cancer-Associated Fibroblasts and Promotes Angiogenesis in Oral Squamous Cell Carcinoma |
| Q58765230 | NOTCH3 expression is linked to breast cancer seeding and distant metastasis |
| Q50094787 | New Opportunities and Challenges to Defeat Cancer Stem Cells |
| Q92405733 | Notch Signaling Activation as a Hallmark for Triple-Negative Breast Cancer Subtype |
| Q36960089 | Notch Signaling and the Skeleton |
| Q64935279 | Notch Signaling as a Regulator of the Tumor Immune Response: To Target or Not To Target? |
| Q46795621 | Notch Signaling in Development, Tissue Homeostasis, and Disease |
| Q26752380 | Notch Signaling in Neuroendocrine Tumors |
| Q55031086 | Notch inhibitor screening reveals an unexpected HES1 heterodimer. |
| Q26797283 | Notch signaling deregulation in multiple myeloma: A rational molecular target |
| Q38845270 | Notch signaling in lung diseases: focus on Notch1 and Notch3. |
| Q26765033 | Notch signaling: its roles and therapeutic potential in hematological malignancies |
| Q41233759 | Notch1 regulates the JNK signaling pathway and increases apoptosis in hepatocellular carcinoma |
| Q47138935 | Notch3 Maintains Luminal Phenotype and Suppresses Tumorigenesis and Metastasis of Breast Cancer via Trans-Activating Estrogen Receptor-α. |
| Q58787441 | Notch3 inhibits epithelial-mesenchymal transition in breast cancer via a novel mechanism, upregulation of GATA-3 expression |
| Q38717772 | Notch3 signaling-mediated melanoma-endothelial crosstalk regulates melanoma stem-like cell homeostasis and niche morphogenesis. |
| Q39899711 | Novel Small-Molecule CX3CR1 Antagonist Impairs Metastatic Seeding and Colonization of Breast Cancer Cells |
| Q47701382 | Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions. |
| Q28066915 | Nrf2 and Notch Signaling in Lung Cancer: Near the Crossroad |
| Q38808628 | Oncogenic roles and drug target of CXCR4/CXCL12 axis in lung cancer and cancer stem cell |
| Q26775594 | Other targeted drugs in melanoma |
| Q33684774 | Overexpression of Musashi-1 protein is associated with progression and poor prognosis of gastric cancer |
| Q92101813 | PD-L1 is overexpressed on breast cancer stem cells through notch3/mTOR axis |
| Q92068565 | PRKD2 Promotes Progression and Chemoresistance of AML via Regulating Notch1 Pathway |
| Q38664687 | Pathobiology of pancreatic cancer: implications on therapy |
| Q92366436 | Precision medicine for human cancers with Notch signaling dysregulation (Review) |
| Q33779227 | Prognostic roles of Notch receptor mRNA expression in human ovarian cancer |
| Q59329484 | Recent advances in research on aspartate β-hydroxylase (ASPH) in pancreatic cancer: A brief update |
| Q44483486 | Relevance of genetic alterations in squamous and small cell lung cancer |
| Q37679979 | Role of Notch signaling pathway in pancreatic cancer |
| Q39453577 | Shifting paradigm of developing biologics for the treatment of pancreatic adenocarcinoma |
| Q35836257 | Small cell lung cancer: will recent progress lead to improved outcomes? |
| Q38658623 | Stem cell transcription factor NANOG in cancers--is eternal youth a curse? |
| Q37721713 | Stimulation of adult hippocampal neurogenesis by physical exercise and enriched environment is disturbed in a CADASIL mouse model. |
| Q37686006 | Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways |
| Q49805810 | Taming the Notch Transcriptional Regulator for Cancer Therapy. |
| Q33361738 | Targeted therapies for pancreatic adenocarcinoma: Where do we stand, how far can we go? |
| Q47850217 | Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy |
| Q64885776 | Targeting Cancer Stem Cells: A Strategy for Effective Eradication of Cancer. |
| Q104135130 | Targeting Notch in oncology: the path forward |
| Q52571053 | Targeting Notch signalling pathway of cancer stem cells |
| Q38441203 | The Potential Roles of Long Noncoding RNAs (lncRNA) in Glioblastoma Development |
| Q52603823 | The Role of Notch3 in Cancer. |
| Q92980181 | The differential distributions of ASPM isoforms and their roles in Wnt signaling, cell cycle progression, and pancreatic cancer prognosis |
| Q92889047 | The role of oncogenic Notch2 signaling in cancer: a novel therapeutic target |
| Q91908379 | Therapeutic Targeting of Notch Signaling Pathway in Hematological Malignancies |
| Q26777880 | Therapies targeting cancer stem cells: Current trends and future challenges |
| Q88334763 | Unravelling disparate roles of NOTCH in bladder cancer |
| Q92826192 | Updates on the Role of Molecular Alterations and NOTCH Signalling in the Development of Neuroendocrine Neoplasms |
| Q64915770 | Variants in Notch signalling pathway genes, PSEN1 and MAML2, predict overall survival in Chinese patients with epithelial ovarian cancer. |
| Q59812783 | miR-181b/Notch2 overcome chemoresistance by regulating cancer stem cell-like properties in NSCLC |
Search more.